EU Antibiotic Use Falls 5% as Resistant Infections Rise
A European Centre for Disease Prevention and Control report finds human antibiotic consumption declined compared with 2019 while resistant bloodstream infections increased.
Updated on Nov. 18, 2026 in COVID-19

Live Poll
Do you think antibiotics are being overused in your own household?
The European Centre for Disease Prevention and Control released an annual report showing a 5% decline in human antibiotic use across EU/EEA countries compared with 2019. Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae rose 72% over the same period.
Why it matters
Antimicrobial resistance is estimated to cause at least 35,000 deaths every year on the continent, making the gap between falling consumption and rising resistant infections a central public health concern. The findings show progress on use reduction is not yet translating into fewer hard-to-treat infections.
The EU's 2030 target is a 20% reduction in antibiotic consumption, and the report's 5% decline reflects progress against that goal, though the 62.5% first-line antibiotic share remains below the 65% target. Whether these figures will reverse the rise in resistant infections is not yet known.
The players
European Centre for Disease Prevention and Control
The ECDC is the European Union agency responsible for identifying and communicating current and emerging threats to human health, including antimicrobial resistance.
The details
The ECDC annual report on antibiotic consumption covers EU/EEA countries and compares 2024 data against the 2019 baseline. The proportion of WHO-designated first-line antibiotics used for common infections increased slightly, while the ECDC also issued a rapid risk assessment on carbapenem-resistant Enterobacterales.
Timeline
2019: Baseline year used for antibiotic consumption and resistance comparisons.
2023: EU leaders established the One Health action plan on antimicrobial resistance with 2030 targets.
2024: Australia reported a 4.8% increase in antibiotic prescriptions and a 25.2% rise in critical resistance.
2030: EU target year for a 20% reduction in antibiotic consumption.
Big Picture
The findings measure progress against the EU's One Health action plan on antimicrobial resistance, established by EU leaders in 2023, which set a 20% reduction target for antibiotic consumption by 2030. Consumption is falling toward that goal, yet resistant bloodstream infections are rising, complicating the plan's assumptions.
Patients may encounter fewer routine antibiotic prescriptions, but resistant infections are becoming harder to treat, which can lengthen hospital stays. Practicing good hygiene and completing prescribed courses only when clinically needed helps limit resistance.
The takeaway
Lower antibiotic use is necessary but not sufficient on its own, since resistant infections have risen even as consumption fell. Monitoring resistance directly remains essential to protecting the effectiveness of existing treatments.
Further reading
Explore more on COVID-19 and related infection trends.
Source note: This article includes information reported by Umn.
Live Poll
Do you think antibiotics are being overused in your own household?



